Results 121 to 130 of about 11,060 (223)

Post‐Market Analysis of the Xenios Console With the Xlung Tubing Kit 230 for Extracorporeal Membrane Oxygenation After Cardiac Surgery

Artificial Organs, Volume 50, Issue 10, Page 1464-1475, October 2026.
This study is a comprehensive post‐market analysis of the Xenios console and XLung kit 230 preconfigured ECMO tubing set in post‐cardiotomy applications. The performance of this device was evaluated and demonstrated in all key clinical areas, with an adequate safety profile.
Luca Conci, Anne‐Kristin Schaefer, Thomas Schlöglhofer, Emilio Osorio‐Jaramillo, Amila Kahrovic, Alvaro Perazzo, Marcus Granegger, Daniel Zimpfer, Dominik Wiedemann, Julia Riebandt   +9 more
wiley   +1 more source

Athletes with Implantable Cardioverter-Defibrillators: A Practical Framework for Device Selection, Programming, and Return-to-Sport Risk Mitigation. [PDF]

J Clin Med
Sharp Dimitri D, Prutkin JM.
europepmc   +1 more source

Different Effects of Defibrillator Shocks on the Myocardial Damage Between Subcutaneous and Transvenous Implantable Cardioverter-Defibrillators. [PDF]

J Cardiovasc Electrophysiol
Kadosaka T, Watanabe M, Nakao M, Koya T, Hagiwara H, Gibo H, Temma T, Mizukami K, Yokoshiki H, Anzai T.   +9 more
europepmc   +1 more source

Response to 'Upgrade procedures of pacemakers or implantable cardioverter-defibrillators require creative clinical decision making and careful planning that begins at the first implantation'. [PDF]

Europace
Keene D, Kaza N, Burri H, Rao A, Nielsen JC.   +4 more
europepmc   +1 more source

Sensing challenges in patients with cardiac amyloidosis and subcutaneous implantable cardioverter-defibrillators. [PDF]

HeartRhythm Case Rep
Zhang K, Patel H, Cha YM, Ezzeddine FM.
europepmc   +1 more source

Implantable Cardioverter-Defibrillators in Children: A 14-Year Population-Based Study. [PDF]

J Arrhythm
Bjeloševič M, Olejník P, Tomko J, Chalupka M, Illíková V.   +4 more
europepmc   +1 more source

Upgrade procedures of pacemakers or implantable cardioverter-defibrillators require creative clinical decision making and careful planning that begins at the first implantation. [PDF]

Europace
Maass AH, Groenveld HF, Rienstra M.
europepmc   +1 more source

Beyond Terminator Narratives: Implantable Cardioverter-Defibrillators as a Lens for Clinical Agentic Artificial Intelligence. [PDF]

Mayo Clin Proc Digit Health
Modi SA.
europepmc   +1 more source

Monocyte-to-High-Density-Lipoprotein Ratio Is Associated with Ventricular Arrhythmia in Patients with Implantable Cardioverter-Defibrillators: A Cross-Sectional Study. [PDF]

J Cardiovasc Dev Dis
Küçükukur M, Ekmekçi C.
europepmc   +1 more source

The Subcutaneous Implantable Cardioverter Defibrillator [PDF]

European Heart Journal, 2017
openaire   +2 more sources